Drugs / Clinisol 15%
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05264727 | May 2023 → Dec 2025 overdue | obesity disorder, type 2 diabetes mellitus | Mayo Clinic | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Clinisol 15% | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05264727 ↗ |
| Route | Intravenous | “Intravenous infusion” NCT05264727 ↗ |